Microbial consortia and IP in Europe
HGF promotes two to partner
Studio Romantic / Shutterstock.com
Developments in microbiome tech are aimed at reducing the need for antibiotics in livestock farming and have led to some notable patenting trends and requirements, explains Rosie McDowell of EIP.
Attempts at reducing antibiotic use in livestock farming have driven an increase in inventive activity in the microbiome technology space over the past decade.
This involves the modulation of the animal’s microbiome to prevent bacterial infection, reducing the need for antibiotics and increasing welfare standards as well as product yield.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
European Patent Office
George Washington Law School
Kirkland & Ellis International LLP
Marks & Clerk
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
The United States Patent and Trademark Office (USPTO)
World Intellectual Property Office
EIP, patents, farming, microbiome, technology, antibiotics, EPO, Patently, inventive step